Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221363
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPáez Carpio, Alfredo-
dc.contributor.authorZarco Contreras, Federico Xavier-
dc.contributor.authorSerrano Alcalá, Elena-
dc.contributor.authorVollmer, Ivan-
dc.contributor.authorPuig, José-
dc.contributor.authorBarberà i Mir, Joan Albert-
dc.contributor.authorGomez, F. M.-
dc.contributor.authorBlanco Vich, Isabel-
dc.date.accessioned2025-06-04T08:32:22Z-
dc.date.available2025-06-04T08:32:22Z-
dc.date.issued2025-02-13-
dc.identifier.issn0009-9260-
dc.identifier.urihttps://hdl.handle.net/2445/221363-
dc.description.abstractAIM Cone beam CT pulmonary angiography (CBCT-PA) has proven to be a valuable technique during balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) in established centres. This study aimed to demonstrate the safety and efficacy of CBCT-PA-guided BPA for CTEPH during the initial period of a BPA program. CBCT-PA improves procedural accuracy by visualising distal thromboembolic lesions and providing real-time guidance, which is critical during program initiation. MATERIALS AND METHODS This single-centre, single-arm study prospectively evaluated patients with CTEPH undergoing BPA from 2017 to 2022. Outcomes of interest included pre-BPA and post-BPA 6-minute walking distance, New York Heart Association Functional Classification (NYHA-FC), mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), N-terminal pro B-type natriuretic peptide (NT-proBNP), and BPA-related adverse events (AEs). Statistical analysis compared pre-BPA and post-BPA results. CBCT-PA was used for three-dimensional (3D) vascular mapping and precise lesion targeting. RESULTS Ninety BPA sessions were performed on 19 patients under CBCT-PA guidance. Significant improvements were observed in mPAP (37.0 mmHg [interquartile range (IQR): 28.0-46.0] vs 25.5 [IQR: 22.8-31.5]; P<0.001), PVR (5.5 Wood units [IQR: 3.4-8.5] vs 3.3 [IQR: 2.7-4.6]; P < 0.001), NYHA-FC I-II rate (8 [42%] vs 18 [94%]; P = 0.04), and NT-proBNP (165 pg/mL [IQR: 82-1146] vs 127.0 [IQR: 57-216]; P = 0.014). Overall AE rate was 14.4%, and major AE rate was 7.7% (all Cardiovascular and Interventional Radiology Society of Europe [CIRSE] grade 3). The haemoptysis rate was 4.4%. No periprocedural deaths were reported. CONCLUSION BPA performed under CBCT-PA guidance appeared to be an effective and safe approach in the program's initial period, helping achieving similar results as established centres.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier BV-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.crad.2025.106847-
dc.relation.ispartofClinical Radiology, 2025, vol. 84-
dc.relation.urihttps://doi.org/10.1016/j.crad.2025.106847-
dc.rightscc-by (c) Páez Carpio et al., 2025-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationHipertensió pulmonar-
dc.subject.classificationAngiografia-
dc.subject.otherPulmonary hypertension-
dc.subject.otherAngiography-
dc.titleCone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2025-05-29T08:09:21Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid40058193-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
PIIS0009926025000522.pdf1.66 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons